Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0034 | 0 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.0094 | 0.703 | 0.703 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0034 | 0 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0094 | 0.703 | 0.5 |
Echinococcus granulosus | caspase 3 | 0.0088 | 0.6288 | 0.6288 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0094 | 0.703 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0094 | 0.703 | 0.703 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0034 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0094 | 0.703 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0034 | 0 | 0.5 |
Onchocerca volvulus | 0.0094 | 0.703 | 1 | |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.012 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0034 | 0 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Echinococcus multilocularis | caspase 3 | 0.0088 | 0.6288 | 0.6288 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0034 | 0 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0094 | 0.703 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0094 | 0.703 | 0.703 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0094 | 0.703 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0094 | 0.703 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0094 | 0.703 | 0.703 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.012 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Echinococcus multilocularis | caspase | 0.012 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0094 | 0.703 | 0.703 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0034 | 0 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0094 | 0.703 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.012 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0.703 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0094 | 0.703 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0094 | 0.703 | 1 |
Echinococcus granulosus | caspase | 0.012 | 1 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0094 | 0.703 | 0.703 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 31.8 uM | Inhibition of human recombinant caspase-3 using Ac-DEVD-AMC as substrate assessed as accumulation of AMC preincubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence assay | ChEMBL. | 23685941 |
IC50 (binding) | = 67.7 uM | Inhibition of human recombinant caspase-7 using Ac-DEVD-AMC as substrate assessed as accumulation of AMC preincubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence assay | ChEMBL. | 23685941 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.